NCT03348774View on ClinicalTrials.gov

Scrutinizing the Heterogeneity of SLE: Defining Phenotypes

UnknownOBSERVATIONAL
Enrollment

950

Participants

Timeline

Start Date

February 9, 2017

Primary Completion Date

June 30, 2018

Study Completion Date

July 30, 2018

Conditions
Systemic Lupus Erythematosus
Trial Locations (1)

M5T2S8

University Health Network, Toronto

Sponsors

Collaborators (1)

GlaxoSmithKline
All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

lead

University Health Network, Toronto

OTHER

NCT03348774 - Scrutinizing the Heterogeneity of SLE: Defining Phenotypes | Biotech Hunter | Biotech Hunter